Citi Pharma Limited (PSX: CPHL)
Pakistan
· Delayed Price · Currency is PKR 95.98
+2.66 (2.85%)
At close: Feb 4, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 21.93 billion as of February 5, 2025. Its market cap has increased by 302.60% in one year.
Market Cap
21.93B
Enterprise Value
22.07B
Revenue
12.93B
Ranking
n/a
PE Ratio
23.28
Stock Price
95.98
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 21.93B, an increase of 206.91%. That is a compound annual growth rate of 36.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 21.93B | 40.92% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 126.21B |
| Abbott Laboratories (Pakistan) | 123.35B |
| The Searle Company | 52.57B |
| Highnoon Laboratories | 46.85B |
| Shifa International Hospitals | 26.87B |
| Ferozsons Laboratories | 14.48B |
| Otsuka Pakistan | 2.19B |